drugset / Trial / NCT00978757

The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

NCT00978757 ↗

Phase 4 Completed 42 enrolled Hospital Italiano de Buenos Aires
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether ketamine is effective to inhibit interleukin 6 synthesis in hepatic resections requiring temporary porto-arterial occlusion.

Timeline

Start
2001-06
Primary completion
2008-06
Completion
2008-06

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Ketamine vs Placebo; p = 0.05; Wilcoxon (Mann-Whitney) NCT00978757 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.25 mg/kg —

Indications